Exploration of Targeted Anti-tumor Therapy

🌟 Join us to share exciting new insights in the field of oncology! 💡 Let's explore breakthroughs and innovations together! #Oncology #Cancer 💕 Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs) https://lnkd.in/gjdVCet

Open Exploration | Exploration of Targeted Anti-tumor Therapy    ⏰ It's time to Explore the mysteries of #TumorTherapy with us!    💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs)    📚 Popular Cited #Perspective sharing! Happy reading!   🎬 The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer   📝 Authors: James Bradley * et al.    ✅ This article belongs to the special issue Immunotherapy Strategies for Non-small Cell Lung Cancer    🏃♂️ Welcome to read, forward, and share the article! https://lnkd.in/g_G2uakn   #CirculatingTumorDNA, #LungCancer, #LiquidBiopsy, #NSCLC

Open Exploration | Exploration of Targeted Anti-tumor Therapy    ⏰ It's time to Explore the mysteries of #TumorTherapy with us!    💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs)    📚 Popular Cited #Perspective sharing! Happy reading!   🎬 Targeted therapies and molecular targets in the therapeutic landscape of advanced urothelial carcinoma: state of the art and future perspectives.   📝 Authors: Irene Testi * et al.   🎯 In this review, authors provide a comprehensive overview of the current and emerging landscape of targeted therapies for aUC. We delved into the opportunities and challenges presented by personalized treatment approaches and explored potential future directions in this rapidly evolving field.    ✅ This article belongs to the special issue Emerging Molecular Targets and Therapies of #GenitourinaryTumors    🏃♂️ Welcome to read, forward, and share the article!   https://lnkd.in/gYbZGirT   #AdvancedUrothelialCarcinoma, #TargetedTherapy, #BladderCancer, #FibroblastGrowthFactorReceptor, #TROP2, #Nectin4, #TKIs, #Her2

Open Exploration | Exploration of Targeted Anti-tumor Therapy ⏰ It's time to Explore the mysteries of #TumorTherapy with us! 💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs) 📚 New online #Editorial sharing! Happy reading! 🎬 Predictive and prognostic biomarkers in cancer: towards the precision medicine era 📝 Authors: Stefano Marletta, Antonio Rizzo, Graziana Spoto, Luca Falzone * et al. ✅ This article belongs to the special issue Predictive and #PrognosticBiomarkers in #Cancer: Towards the #PrecisionMedicine Era 🏃♂️ Welcome to read, forward, and share the article! https://lnkd.in/gyfS8smi

Open Exploration | Exploration of Targeted Anti-tumor Therapy 💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APC) -------------------- 🚀 Introducing Our Stunning New Journal Flyer Design! 📰 We’re thrilled to unveil our vibrant promotional flyer for the journal! 💡 What do you think of the design? 👇Talk to us and share your interest in the field of oncology—your thoughts matter to us! #JournalPromotion #ConferencesPromote #Publishers #Cancer #Oncology

Open Exploration | Exploration of Targeted Anti-tumor Therapy 💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APC) -------------------- 🚀 Introducing Our Stunning New Journal Flyer Design! 📰 We’re thrilled to unveil our vibrant promotional flyer for the journal! 💡 What do you think of the design? 👇Talk to us and share your interest in the field of oncology—your thoughts matter to us! #JournalPromotion #ConferencesPromote #Publishers #Cancer #Oncology

How are you today? Tell us what you want to hear from us. If you want to stay up-to-date with us, follow our Page.

Open Exploration | Exploration of Targeted Anti-tumor Therapy ⏰ It's time to Explore the mysteries of #TumorTherapy with us! 💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs) 📚 New #OriginalArticle sharing! Happy reading! 🎬 Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer 📝 Authors: Aram A. Musaelyan* et al. 🎯 Aim: The present study aims to evaluate the efficacy of rechallenge with immune checkpoint inhibitors (ICIs) compared to chemotherapy and the predictive role of clinical parameters in non-small cell lung cancer (NSCLC) patients who were rechallenged 🔎 Academic Editor: Nicola Normanno, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Italy ✅ This article belongs to the special issue #Immunotherapy #Strategies for Non-small Cell #LungCancer 🏃♂️ Welcome to read, forward, and share the article! https://lnkd.in/gUT4ckZW #ImmuneCheckpointInhibitors, #NonSmallCellLungCancer, #Rechallenge, #ObjectiveResponse, #ECOG, #NeutrophilToLymphocyteRatio, #PredictiveMarker

Open Exploration | Exploration of Targeted Anti-tumor Therapy ⏰ It's time to Explore the mysteries of #TumorTherapy with us! 💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs) 📚 Popular Cited #Review sharing! Happy reading! 🎬 Tri-specific killer engager: unleashing multi-synergic power against cancer 📝 Authors: Seiji Okada * et al. ✅ This article belongs to the special issue Novel Strategies and Targets for #Immunotherapy of #Cancer 🏃♂️ Welcome to read, forward, and share the article! https://lnkd.in/gWKETupu #TriSpecificKillerEngager, #NaturalKillerCell, #Immunotherapy, #Cancer

Open Exploration | Exploration of Targeted Anti-tumor Therapy    ⏰ It's time to Explore the mysteries of #TumorTherapy with us!   💕 Tips! Welcome to your submission (Indexed in #PubMed #Scopus and #GoogleScholar with no #APCs)    📚 Popular Cited #MetaAnalysis sharing! Happy reading!   🎬 Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis   📝 Authors: Jieer Ying * et al.    ✅ This article belongs to the special issue Emerging Molecular Targets and Therapies of #Genitourinary   🏃♂️ Welcome to read, forward, and share the article!    https://lnkd.in/gKvA-9AB   #HepatocellularCarcinoma, anti-programmed death 1/ligand-1 antibody, anti-vascular endothelial growth factor antibody, tyrosine kinase inhibitor, network meta-analysis